HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The roles of bone morphogenetic protein 2 in perfluorooctanoic acid induced developmental cardiotoxicity and l-carnitine mediated protection.

Abstract
Perfluorooctanoic acid (PFOA), a wide spread environmental pollutant, was associated with developmental cardiotoxicity in chicken embryo, while the underlying molecular mechanism had not been fully elucidated. In the current study, 2 mg/kg (egg weight) PFOA and/or 100 mg/kg (egg weight) l-carnitine were exposed to embryonic day zero (ED0) chicken embryo via air cell injection, and then bone morphogenic protein 2 (BMP2) silencing lentivirus or BMP2 recombinant protein were introduced into ED2 embryo. Electrocardiography and histological methods were utilized to assess the cardiac function and morphology in hatchling chickens, respectively. Consistent with previous results, 2 mg/kg PFOA exposure at ED0 significantly elevated heart rate and thinned right ventricular wall in hatchling chickens, while l-carnitine co-treatment reverted such changes. BMP2 silencing induced very similar changes in hatchling chicken hearts as PFOA exposure, while co-exposure of recombinant BMP2 protein alleviated PFOA-induced changes. l-carnitine exposure alleviated the BMP2-silencing induced changes as well. Western blotting revealed that PFOA exposure enhanced BMP2 expression and suppressed pSMAD1 expression in ED15 chicken embryo hearts, while both changes were reverted by l-carnitine co-exposure. Furthermore, silencing of BMP2 significantly increased the expression level of PPAR alpha in ED15 chicken embryo hearts, while silencing of PPAR alpha did not have significant impact on BMP2 expression. In conclusion, BMP2/pSMAD1 signaling participates in the PFOA-induced developmental cardiotoxicity in chicken embryo, which is likely located upstream of PPAR alpha for this particular endpoint. Protection of BMP2 signaling might contribute to l-carnitine mediated protection against PFOA-induced developmental cardiotoxicity.
AuthorsNa Lv, Meng Zhao, Yantao Han, Lianhua Cui, Weizhen Zhong, Chunbo Wang, Qixiao Jiang
JournalToxicology and applied pharmacology (Toxicol Appl Pharmacol) Vol. 352 Pg. 68-76 (08 01 2018) ISSN: 1096-0333 [Electronic] United States
PMID29800642 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2018 Elsevier Inc. All rights reserved.
Chemical References
  • BMP2 protein, human
  • Bone Morphogenetic Protein 2
  • Caprylates
  • Environmental Pollutants
  • Fluorocarbons
  • PPAR alpha
  • Recombinant Proteins
  • Smad1 Protein
  • perfluorooctanoic acid
  • Carnitine
Topics
  • Animals
  • Bone Morphogenetic Protein 2 (genetics, metabolism, pharmacology)
  • Caprylates (toxicity)
  • Cardiotoxicity
  • Carnitine (pharmacology)
  • Chick Embryo
  • Cytoprotection
  • Environmental Pollutants (toxicity)
  • Fluorocarbons (toxicity)
  • Gene Expression Regulation, Developmental
  • Gene Silencing
  • Heart (drug effects, embryology, physiopathology)
  • Heart Diseases (chemically induced, embryology, physiopathology, prevention & control)
  • Heart Rate (drug effects)
  • PPAR alpha (genetics, metabolism)
  • Phosphorylation
  • Recombinant Proteins (pharmacology)
  • Signal Transduction (drug effects)
  • Smad1 Protein (genetics, metabolism)
  • Ventricular Function, Right (drug effects)
  • Ventricular Remodeling (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: